321
Participants
Start Date
May 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
RLX030 (serelaxin)
RLX030 (serelaxin) was administered according to a weight-range adjusted dosing regimen at a nominal dose of 30 μg/kg/day as a continuous IV infusion for 48 hours.
Placebo
Matching placebo of serelaxin was administered as a continuous IV infusion for 48 hours.
Novartis Investigative Site, Geelong
Novartis Investigative Site, Berlin
Novartis Investigative Site, Villamartín
Novartis Investigative Site, Berlin
Novartis Investigative Site, Greifswald
Novartis Investigative Site, Turku
Novartis Investigative Site, Monza
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Kiel
Novartis Investigative Site, Brescia
Novartis Investigative Site, Meselik / Eskisehir
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Málaga
Novartis Investigative Site, Hanover
Novartis Investigative Site, Jacksonville
Novartis Investigative Site, South Miami
Novartis Investigative Site, Haydarpasa/Istanbul
Novartis Investigative Site, Knoxville
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Seville
Novartis Investigative Site, Kocaeli
Novartis Investigative Site, Cortona
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Sivas
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Colorado Springs
Novartis Investigative Site, Anaheim
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Vimercate
Novartis Investigative Site, Craiova
Novartis Investigative Site, Târgu Mureş
Novartis Investigative Site, Sibiu
Novartis Investigative Site, Chapel Hill
Novartis Investigative Site, Richmond
Novartis Investigative Site, Melbourne
Novartis Investigative Site, Brno - Bohunice
Novartis Investigative Site, Jihlava
Novartis Investigative Site, Prague
Novartis Investigative Site, Dresden
Novartis Investigative Site, Grünstadt
Novartis Investigative Site, Jena
Novartis Investigative Site, Sneek
Novartis Investigative Site, Groningen
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Oslo
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Diskapi / Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY